Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4751548
Max Phase: Preclinical
Molecular Formula: C29H36N2O7
Molecular Weight: 524.61
Molecule Type: Unknown
Associated Items:
ID: ALA4751548
Max Phase: Preclinical
Molecular Formula: C29H36N2O7
Molecular Weight: 524.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)[C@H]1[C@@H]2C=C[C@@H]3[C@@H](C/C=C\C(N)=O)[C@H](/C=C/C(=O)C4=C(O)[C@H](CCC(=O)O)NC4=O)C[C@@H]3[C@H]2C[C@H]1C
Standard InChI: InChI=1S/C29H36N2O7/c1-14-12-20-19(26(14)15(2)32)8-7-18-17(4-3-5-24(30)34)16(13-21(18)20)6-10-23(33)27-28(37)22(31-29(27)38)9-11-25(35)36/h3,5-8,10,14,16-22,26,37H,4,9,11-13H2,1-2H3,(H2,30,34)(H,31,38)(H,35,36)/b5-3-,10-6+/t14-,16-,17+,18-,19-,20+,21+,22+,26+/m1/s1
Standard InChI Key: WCAHSUVVSSTENQ-XNKQKVPSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 524.61 | Molecular Weight (Monoisotopic): 524.2523 | AlogP: 2.63 | #Rotatable Bonds: 10 |
Polar Surface Area: 163.86 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.59 | CX Basic pKa: | CX LogP: 1.71 | CX LogD: -4.65 |
Aromatic Rings: 0 | Heavy Atoms: 38 | QED Weighted: 0.19 | Np Likeness Score: 1.40 |
1. Jiao YJ,Liu Y,Wang HX,Zhu DY,Shen YM,Li YY. (2020) Expression of the Clifednamide Biosynthetic Pathway in Streptomyces Generates 27,28-seco-Derivatives., 83 (9.0): [PMID:32915576] [10.1021/acs.jnatprod.0c00900] |
Source(1):